Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
FLAVONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FLAVONE
×
Maximum Phase:
2
First Approval:
None
UNII:
S2V45N7G3B
Molecule Type:
Small molecule
Molecular Formula:
C15H10O2
Molecular Weight:
222.24
AlogP:
3.46
PSA:
30.21
HBD:
0.0
HBA:
#RotB:
1.0
Source:
PALIRODEN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PALIRODEN
×
Maximum Phase:
2
First Approval:
None
UNII:
17VJ76L90T
Molecule Type:
Small molecule
Molecular Formula:
C26H24F3N
Molecular Weight:
407.48
AlogP:
6.7
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
5.0
Source:
BMS-986094
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
BMS-986094
×
Maximum Phase:
2
First Approval:
None
UNII:
62F4AD749Y
Molecule Type:
Small molecule
Molecular Formula:
C30H39N6O9P
Molecular Weight:
658.65
AlogP:
3.35
PSA:
202.4
HBD:
4.0
HBA:
#RotB:
11.0
Source:
ALVESPIMYCIN
(2)
Small molecule
Heat shock protein HSP90 inhibitor
Unknown
Investigational
Unknown
ALVESPIMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
001L2FE0M3
Molecule Type:
Small molecule
Molecular Formula:
C32H48N4O8
Molecular Weight:
616.76
AlogP:
1.91
PSA:
169.52
HBD:
4.0
HBA:
#RotB:
7.0
Source:
FLUBROBENGUANE F18
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FLUBROBENGUANE F18
×
Maximum Phase:
2
First Approval:
None
UNII:
8LF7W971UM
Molecule Type:
Small molecule
Molecular Formula:
C11H15BrFN3O
Molecular Weight:
303.17
AlogP:
2.17
PSA:
71.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ELVUCITABINE
(2)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
Unknown
Investigational
Unknown
ELVUCITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
M09BUF90C0
Molecule Type:
Small molecule
Molecular Formula:
C9H10FN3O3
Molecular Weight:
227.19
AlogP:
-0.59
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
RUTIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RUTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
5G06TVY3R7
Molecule Type:
Small molecule
Molecular Formula:
C27H30O16
Molecular Weight:
610.52
AlogP:
-1.69
PSA:
269.43
HBD:
10.0
HBA:
#RotB:
6.0
Source:
AFEGOSTAT TARTRATE
(2)
Small molecule
Beta-glucocerebrosidase stabiliser
Unknown
Investigational
Unknown
AFEGOSTAT TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
285ZJJ9773
Molecule Type:
Small molecule
Molecular Formula:
C10H19NO9
Molecular Weight:
297.26
AlogP:
-2.08
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
P
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
P
×
Maximum Phase:
2
First Approval:
None
UNII:
N939YFB9KP
Molecule Type:
Small molecule
Molecular Formula:
C13H20N4O3
Molecular Weight:
280.33
AlogP:
-0.02
PSA:
82.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BTRX-335140
(2)
Small molecule
Kappa opioid receptor antagonist
Unknown
Investigational
Unknown
BTRX-335140
×
Maximum Phase:
2
First Approval:
None
UNII:
XK5ILZ28KI
Molecule Type:
Small molecule
Molecular Formula:
C25H32FN5O2
Molecular Weight:
453.56
AlogP:
4.34
PSA:
76.31
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TARAFENACIN
(2)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
Unknown
Investigational
Unknown
TARAFENACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LDV98UN52Y
Molecule Type:
Small molecule
Molecular Formula:
C21H20F4N2O2
Molecular Weight:
408.39
AlogP:
4.48
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
4.0
Source:
EVT-101
(2)
Small molecule
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
Unknown
Investigational
Unknown
EVT-101
×
Maximum Phase:
2
First Approval:
None
UNII:
B55T45AA8F
Molecule Type:
Small molecule
Molecular Formula:
C16H15Cl2F3N4
Molecular Weight:
391.22
AlogP:
3.77
PSA:
43.6
HBD:
0.0
HBA:
#RotB:
4.0
Source:
OLMUTINIB
(2)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Investigational
Unknown
OLMUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
CHL9B67L95
Molecule Type:
Small molecule
Molecular Formula:
C26H26N6O2S
Molecular Weight:
486.6
AlogP:
5.1
PSA:
82.62
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ARRY-382
(2)
Small molecule
Macrophage colony stimulating factor receptor inhibitor
Unknown
Investigational
Unknown
ARRY-382
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VALEMETOSTAT TOSYLATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALEMETOSTAT TOSYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
6N79I7X5II
Molecule Type:
Small molecule
Molecular Formula:
C33H42ClN3O7S
Molecular Weight:
660.23
AlogP:
4.49
PSA:
83.66
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FARAMPATOR
(2)
Small molecule
Glutamate receptor ionotropic AMPA positive allosteric modulator
Unknown
Investigational
Unknown
FARAMPATOR
×
Maximum Phase:
2
First Approval:
None
UNII:
7X6P5N8K2L
Molecule Type:
Small molecule
Molecular Formula:
C12H13N3O2
Molecular Weight:
231.25
AlogP:
1.85
PSA:
59.23
HBD:
0.0
HBA:
#RotB:
1.0
Source:
LERSIVIRINE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
LERSIVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
R3ZGC15A9A
Molecule Type:
Small molecule
Molecular Formula:
C17H18N4O2
Molecular Weight:
310.36
AlogP:
2.54
PSA:
94.86
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PF-03654746
(2)
Small molecule
Histamine H3 receptor antagonist
Unknown
Investigational
Unknown
PF-03654746
×
Maximum Phase:
2
First Approval:
None
UNII:
G3QE979K1X
Molecule Type:
Small molecule
Molecular Formula:
C18H24F2N2O
Molecular Weight:
322.4
AlogP:
3.13
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LUMICITABINE
(2)
Small molecule
RNA-directed RNA polymerase L inhibitor
Unknown
Investigational
Unknown
LUMICITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
BNW5PQ52G1
Molecule Type:
Small molecule
Molecular Formula:
C18H25ClFN3O6
Molecular Weight:
433.86
AlogP:
1.44
PSA:
122.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MK-0773
(2)
Small molecule
Androgen Receptor modulator
Unknown
Investigational
Unknown
MK-0773
×
Maximum Phase:
2
First Approval:
None
UNII:
5730VNW22X
Molecule Type:
Small molecule
Molecular Formula:
C27H34FN5O2
Molecular Weight:
479.6
AlogP:
4.13
PSA:
90.98
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PRALICIGUAT
(2)
Small molecule
Soluble guanylate cyclase activator
Unknown
Investigational
Unknown
PRALICIGUAT
×
Maximum Phase:
2
First Approval:
None
UNII:
R1S0H458SA
Molecule Type:
Small molecule
Molecular Formula:
C21H14F8N6O2
Molecular Weight:
534.37
AlogP:
4.59
PSA:
101.89
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LCL-161
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LCL-161
×
Maximum Phase:
2
First Approval:
None
UNII:
6TNS415Y3P
Molecule Type:
Small molecule
Molecular Formula:
C26H33FN4O3S
Molecular Weight:
500.64
AlogP:
3.85
PSA:
91.4
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IRSENONTRINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IRSENONTRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
54QB00NNRB
Molecule Type:
Small molecule
Molecular Formula:
C22H22N4O3
Molecular Weight:
390.44
AlogP:
3.53
PSA:
82.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ALDUMASTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALDUMASTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
EI4HZ6P03E
Molecule Type:
Small molecule
Molecular Formula:
C20H24F2N4O3
Molecular Weight:
406.43
AlogP:
1.77
PSA:
81.75
HBD:
2.0
HBA:
#RotB:
5.0
Source:
METHYLONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
METHYLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GEPIRONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GEPIRONE
×
Maximum Phase:
2
First Approval:
None
UNII:
JW5Y7B8Z18
Molecule Type:
Small molecule
Molecular Formula:
C19H29N5O2
Molecular Weight:
359.47
AlogP:
1.55
PSA:
69.64
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SANFETRINEM CILEXETIL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SANFETRINEM CILEXETIL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOLIGLURAX
(2)
Small molecule
Metabotropic glutamate receptor 4 positive allosteric modulator
Unknown
Investigational
Unknown
FOLIGLURAX
×
Maximum Phase:
2
First Approval:
None
UNII:
FR50CP1D6W
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O3S
Molecular Weight:
421.52
AlogP:
4.26
PSA:
71.09
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BINDARIT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BINDARIT
×
Maximum Phase:
2
First Approval:
None
UNII:
JQ11LH711M
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3
Molecular Weight:
324.38
AlogP:
3.46
PSA:
64.35
HBD:
1.0
HBA:
#RotB:
6.0
Source:
SURINABANT
(2)
Small molecule
Cannabinoid CB1 receptor antagonist
Unknown
Investigational
Unknown
SURINABANT
×
Maximum Phase:
2
First Approval:
None
UNII:
SF8R9VCB0X
Molecule Type:
Small molecule
Molecular Formula:
C23H23BrCl2N4O
Molecular Weight:
522.27
AlogP:
6.3
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LUNACALCIPOL
(2)
Small molecule
Vitamin D receptor agonist
Unknown
Investigational
Unknown
LUNACALCIPOL
×
Maximum Phase:
2
First Approval:
None
UNII:
XN4TL6M50Z
Molecule Type:
Small molecule
Molecular Formula:
C28H42O4S
Molecular Weight:
474.71
AlogP:
5.8
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SAFIMALTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SAFIMALTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRICIRIBINE PHOSPHATE
(2)
Small molecule
Serine/threonine-protein kinase AKT inhibitor
Unknown
Investigational
Unknown
TRICIRIBINE PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5L5GE3DV88
Molecule Type:
Small molecule
Molecular Formula:
C13H17N6O7P
Molecular Weight:
400.29
AlogP:
-1.77
PSA:
188.78
HBD:
5.0
HBA:
#RotB:
4.0
Source:
BISEGLIPTIN
(2)
Small molecule
Dipeptidyl peptidase IV inhibitor
Unknown
Investigational
Unknown
BISEGLIPTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9U5KQ79OK6
Molecule Type:
Small molecule
Molecular Formula:
C18H26FN3O3
Molecular Weight:
351.42
AlogP:
1.69
PSA:
82.43
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VERUBULIN
(2)
Small molecule
Tubulin disrupting agent
Unknown
Investigational
Unknown
VERUBULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
X97O9FTB92
Molecule Type:
Small molecule
Molecular Formula:
C17H17N3O
Molecular Weight:
279.34
AlogP:
3.71
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TRELANSERIN
(2)
Small molecule
Serotonin 1b (5-HT1b) receptor antagonist
Unknown
Investigational
Unknown
TRELANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
QUD44MBL5S
Molecule Type:
Small molecule
Molecular Formula:
C24H24FN5O2S
Molecular Weight:
465.55
AlogP:
2.6
PSA:
84.46
HBD:
1.0
HBA:
#RotB:
6.0
Source:
1
2
…
158
159
160
161
162
163
164
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA